NCI funding boosts cancer trials collaboration with Canada

the ONA take:

The US National Cancer Institute (NCI) has awarded $15 million in funding to the NCIC Clinical Trials Group (CTG) at Queen’s University in Kingston, Ontario, Canada. This funding will give Canadian cancer patients access to international clinical trials. It also allows NCIC CTG to open its trials to US groups. The NCIC CTG began collaborating with US-based groups in the 1990s and has received funding from the NCI since 1997.

NCI funding boosts cancer trials collaboration with Canada
NCI funding boosts cancer trials collaboration with Canada
Kingston, ON - The NCIC Clinical Trials Group (CTG) at Queen’s University has been awarded $15 million in funding from the U.S. National Institutes of Health through the U.S. National Cancer Institute (NCI) to strengthen its work leading major cancer clinical trials in Canada. This funding from ...
READ FULL ARTICLE From Labcanada
Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs